Silver Book Fact

For beneficiaries with wet age-related macular degeneration (AMD), annual Medicare part B payments for vision care increased from $1,504 per beneficiary in 1994 to $3,263 in 2006–due in large part to anti-VEGF treatments.

Day S, Acquah K, Lee P, Mruthyunjaya P, et al. Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007. Ophthalmol. 2011; 152(6): 1014-20. http://www.ajo.com/article/S0002-9394%2811%2900410-7/abstract

Reference

Title
Medicare Costs for Neovascular Age-Related Macular Degeneration, 1994-2007
Publication
Ophthalmol
Publication Date
2011
Authors
Day S, Acquah K, Lee P, Mruthyunjaya P, et al.
Volume & Issue
Volume 152, Issue 6
Pages
1014-20
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Percent of Blindness in 2010 Due to DR by Region
     
  • Cataracts removal over age 85
    One in 2 Americans aged 85 years or older stated that their cataracts have been removed.  
  • Quality of life of diabetic retinopathy patients
    A study evaluating quality of life using utility values, found that diabetic retinopathy patients with best-corrected visual acuity of 20/20 and 20/25, were willing to trade 15% of their remaining…  
  • Vision conditions or problems cause activity limitations in 8.3% of Americans age 85 and older.  
  • Close to 50% of participants in the NEI-sponsored Los Angeles Latino Eye Study (LALES) who had diabetes, also had diabetic retinopathy.